TradingView
MarketMoversReport
7 Jul 2022 pukul 17.47

Intercept Announces Positive Data in Fibrosis due to NASH Pembelian

NASDAQ:ICPT1D

Deskripsi

⋅
ICPT: Intercept Pharmaceuticals, Inc.
2022-07-07 07:30:00
Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA)
Beyond Technical Analysis
Lebih lanjut